These phenomena suggest that the expression of HLA-G in RCC cells contributes to impaired immune recognition of CTL, NK, and lymphokine activated killer cells, which may play a role in avoiding immune surveillance. This evidence concerns the gene HLA-G and renal cell adenocarcinoma.